HIGHBRIDGE CAPITAL MANAGEMENT LLC - PHOENIX BIOTECH ACQUISITION ownership

Back to all holdings Add to watchlist

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 37 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2022$11,035,000
+6.9%
1,092,529
+6.1%
0.16%
-34.0%
Q2 2022$10,323,000
-0.2%
1,029,262
-0.5%
0.24%
-2.5%
Q1 2022$10,340,000
+0.5%
1,033,950
-0.4%
0.24%
+7.1%
Q4 2021$10,285,000–1,037,794–0.22%–
 Download
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2021
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders